BioCentury
ARTICLE | Clinical News

CollaRx Bupivacaine Topical: Phase II start

October 22, 2007 7:00 AM UTC

Next half, Innocoll plans to begin a placebo-controlled, U.S. Phase II trial in 30-40 patients. ...